TITLE

The Procalcitonin And Survival Study (PASS) -- A Randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients

AUTHOR(S)
Jensen, Jens-Ulrik; Lundgren, Bettina; Hein, Lars; Mohr, Thomas; Petersen, Pernille L.; Andersen, Lasse H.; Lauritsen, Anne Ø; Hougaard, Sine; Mantoni, Teit; Bømler, Bonnie; Thornberg, Klaus J.; Thormar, Katrin; Løken, Jesper; Steensen, Morten; Carl, Peder; Petersen, J. Asger; Tousi, Hamid; Søe-Jensen, Peter; Bestle, Morten; Hestad, Søren
PUB. DATE
January 2008
SOURCE
BMC Infectious Diseases;2008, Vol. 8 Issue 1, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Sepsis and complications to sepsis are major causes of mortality in critically ill patients. Rapid treatment of sepsis is of crucial importance for survival of patients. The infectious status of the critically ill patient is often difficult to assess because symptoms cannot be expressed and signs may present atypically. The established biological markers of inflammation (leucocytes, Creactive protein) may often be influenced by other parameters than infection, and may be unacceptably slowly released after progression of an infection. At the same time, lack of a relevant antimicrobial therapy in an early course of infection may be fatal for the patient. Specific and rapid markers of bacterial infection have been sought for use in these patients. Methods: Multi-centre randomized controlled interventional trial. Powered for superiority and non-inferiority on all measured end points. Complies with, "Good Clinical Practice" (ICH-GCP Guideline (CPMP/ICH/135/95, Directive 2001/20/EC)). Inclusion: 1) Age ≥ 18 years of age, 2) Admitted to the participating intensive care units, 3) Signed written informed consent. Exclusion: 1) Known hyper-bilirubinaemia. or hypertriglyceridaemia, 2) Likely that safety is compromised by blood sampling, 3) Pregnant or breast feeding. Computerized Randomisation: Two arms (1:1), n = 500 per arm: Arm 1: standard of care. Arm 2: standard of care and Procalcitonin guided diagnostics and treatment of infection. Primary Trial Objective: To address whether daily Procalcitonin measurements and immediate diagnostic and therapeutic response on day-to-day changes in procalcitonin can reduce the mortality of critically ill patients. Discussion: For the first time ever, a mortality-endpoint, large scale randomized controlled trial with a biomarker-guided strategy compared to the best standard of care, is conducted in an Intensive care setting. Results will, with a high statistical power answer the question: Can the survival of critically ill patients be improved by actively using biomarker procalcitonin in the treatment of infections? 700 critically ill patients are currently included of 1000 planned (June 2008). Two interim analyses have been passed without any safety or futility issues, and the third interim analysis is soon to take place. Trial registration number at clinicaltrials.gov: Id. nr.: NCT00271752).
ACCESSION #
35709560

 

Related Articles

  • Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in Spain. Suarez, David; Ferrer, Ricard; Artigas, Antonio; Azkarate, Izaskun; Garnacho-Montero, José; Gomà, Gemma; Levy, Mitchell; Ruiz, Juan // Intensive Care Medicine;Mar2011, Vol. 37 Issue 3, p444 

    Context: Severe sepsis is associated with high mortality and increased costs. The 'Surviving Sepsis Campaign' (SSC) protocol was developed as an international initiative to reduce mortality. However, its cost-effectiveness is unknown. Objective: To determine the cost-effectiveness of the SSC...

  • Plasma apolipoprotein CI correlates with increased survival in patients with severe sepsis. Berbée, Jimmy; Hoogt, Caroline; Haas, Carla; Kessel, Kok; Dallinga-Thie, Geesje; Romijn, Johannes; Havekes, Louis; Leeuwen, Henk; Rensen, Patrick // Intensive Care Medicine;May2008, Vol. 34 Issue 5, p907 

    We recently reported that apolipoprotein CI (apoCI) protects against the development of murine bacterial sepsis. We now examined the time course of plasma apoCI levels in survivors and non-survivors of severe sepsis. Prospective study in patients meeting predefined criteria for severe sepsis....

  • Early identification of sepsis and mortality risks through simple, rapid clot-waveform analysis: Implications of lipoprotein-complexed C reactive protein formation. Cheng Hock Toh; Ticknor, Lawrence O.; Downey, Colin; Giles, Alan R.; Paton, Ray C.; Wenstone, Richard // Intensive Care Medicine;Jan2003, Vol. 29 Issue 1, p55 

    Objective. To determine if the rapid waveform profile of the activated partial thromboplastin time (aPTT) assay, which detects lipoprotein-complexed C reactive protein (LCCRP) formation, predicts sepsis and mortality in critically ill patients. Design. Observational, cohort study. Setting....

  • Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Alberti, Corinne; Brun-Buisson, Christian; Burchardi, Hilmar; Martin, Claudio; Goodman, Sergey; Artigas, Antonio; Sicignano, Alberto; Palazzo, Mark; Moreno, Rui; Boulmé, Ronan; Lepage, Eric; Le Gall, Jean Roger // Intensive Care Medicine;Feb2002, Vol. 28 Issue 2, p108 

    Objectives: To examine the incidence of infections and to describe them and their outcome in intensive care unit (ICU) patients. Design and setting: International prospective cohort study in which all patients admitted to the 28 participating units in eight countries between May 1997 and May...

  • Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006–8: a review. McClure, J. H.; Cooper, G. M.; Clutton-Brock, T. H. // BJA: The British Journal of Anaesthesia;Aug2011, Vol. 107 Issue 2, p127 

    This review of the eighth report of the United Kingdom Enquiries into Maternal Deaths, Saving Mothers' Lives, is written primarily for anaesthetists and critical care specialists involved in both maternity and gynaecology services. Direct maternal deaths from systemic sepsis secondary to...

  • Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. José Garnacho-Montero; Carlos Ortiz-Leyba; Inmaculada Herrera-Melero; Teresa Aldabó-Pallás; Aurelio Cayuela-Dominguez; Juan A. Marquez-Vacaro; Jesus Carbajal-Guerrero; Jose L. Garcia-Garmendia // Journal of Antimicrobial Chemotherapy (JAC);Feb2008, Vol. 61 Issue 2, p436 

    Objectives To determine the attributable mortality and excess length of stay (LOS) associated with the use of inadequate empirical antimicrobial therapy in patients with sepsis at admission to the intensive care unit (ICU). Methods A retrospective matched cohort study was performed using a...

  • Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective study. Longxiang Su; Lin Feng; Changting Liu; Zhaoxu Jiang; Ming Li; Kun Xiao; Peng Yan; Yanhong Jia; Dan Feng; Lixin Xie // BMC Nephrology;2012, Vol. 13 Issue 1, p123 

    Background: Sepsis is a common syndrome in critically ill patients and easily leads to the occurrence of acute kidney injury (AKI), with high mortality rates. This study aimed to investigate the diagnostic value of urine soluble CD163 (sCD163) for identification of sepsis, severity of sepsis,...

  • Erratum to: Sepsis without borders. Moreno, Rui; Martin, Greg // Intensive Care Medicine;Feb2014, Vol. 40 Issue 2, p303 

    A correction to the article "Sepsis Without Borders" that was published in the journal in 2013 is presented.

  • Calibration strategies to validate predictive models: is new always better? Serrano, Nicolás // Intensive Care Medicine;Aug2012, Vol. 38 Issue 8, p1246 

    An introduction to the journal is presented in which the editor discusses the multicenter study that compares the performance of Simplified Acute Physiology Score (SAPS) II and 3 in predicting hospital mortality.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics